about
Genetic markers and biomarkers for age-related macular degeneration.Enhanced HtrA2/Omi expression in oxidative injury to retinal pigment epithelial cells and murine models of neurodegeneration.Peroxisome Proliferator-Activated Receptor Expression in Murine Models and Humans with Age-related Macular Degeneration.Evidence for enhanced tissue factor expression in age-related macular degeneration.AAV5-mediated sFLT01 gene therapy arrests retinal lesions in Ccl2(-/-)/Cx3cr1(-/-) miceAn apolipoprotein E variant may protect against age-related macular degeneration through cytokine regulation.Polymerase chain reaction in the diagnosis of uveitis.Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration.Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration.Hypomethylation of the IL17RC promoter associates with age-related macular degeneration.Peroxisome proliferator-activated receptor and age-related macular degenerationOcular toxicity of fludarabine: a purine analogCcl2/Cx3cr1-deficient mice: an animal model for age-related macular degenerationA variant of the Cockayne syndrome B gene ERCC6 confers risk of lung cancer.Constancy of ERp29 expression in cultured retinal pigment epithelial cells in the Ccl2/Cx3cr1 deficient mouse model of age-related macular degenerationControversial view of a genetically altered mouse model of focal retinal degeneration.Altered chemokine profile associated with exacerbated autoimmune pathology under conditions of genetic interferon-gamma deficiency.Exacerbation of retinal degeneration and choroidal neovascularization induced by subretinal injection of Matrigel in CCL2/MCP-1-deficient mice.Differential promoter activities of functional haplotypes in the 5'-flanking region of human sulfotransferase 1A1.
P50
Q33301643-5DD248DB-B0EC-4B37-AF00-BEB50D27D231Q33992324-532EAF8E-4ABF-41D1-BCFD-D9B338AAB455Q34386751-86A11468-C037-4C4C-B6B4-A739441323A9Q34744314-31DD4429-9E91-4B04-A8BE-FAFE47858292Q35106359-62D5BD77-918D-4EFE-A973-45987D66E0BFQ35855800-D3A0682D-60AE-4AEB-8800-E9117A0EC29FQ36080381-1C9CE225-7744-474E-AA8D-6883B22E7CEFQ36102995-6059BD44-ABB1-4675-80EE-828DCE84920CQ36350410-67E21298-B0CC-48FF-BBF9-B827BE012C70Q36442673-6AD2D80B-A95E-4790-9B8F-9FFA6F5ECCEAQ36446030-AF883E66-7074-46E6-9D3E-93A255E5C9D7Q36638487-A046F588-87F5-4B61-8979-CBD7F73993A7Q36692827-4A4EF42C-349B-4DB2-A26A-B7E47A798777Q36739715-D18087E9-3DE7-4B8E-9682-4EA4CD55A4B8Q36874049-C721DAAB-60C0-44D1-84CA-AB995AFCA353Q36891992-E7A43AE9-82BC-4B4D-9C66-58C389DF579FQ37373152-B72CAAAB-081B-4BAC-96FB-000105708A32Q42448644-2D8F422B-8351-41B3-B513-9FAE95CA198CQ50488994-21E86D72-F05B-4D9C-B935-08FEC98CA846
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jingsheng Tuo
@ast
Jingsheng Tuo
@en
Jingsheng Tuo
@es
Jingsheng Tuo
@nl
Jingsheng Tuo
@sl
type
label
Jingsheng Tuo
@ast
Jingsheng Tuo
@en
Jingsheng Tuo
@es
Jingsheng Tuo
@nl
Jingsheng Tuo
@sl
prefLabel
Jingsheng Tuo
@ast
Jingsheng Tuo
@en
Jingsheng Tuo
@es
Jingsheng Tuo
@nl
Jingsheng Tuo
@sl
P106
P31
P496
0000-0002-1372-7810